Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumours

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 4, 1996, Pages 577-586

  Azcona, C ^a   Castro, L ^a   Crespo, E ^a   Jimenez M ^a   Sierrasesumaga L ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MEGESTROL ACETATE;

ADOLESCENT; ANOREXIA; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; INFANT; MALE; MALNUTRITION; NUTRITION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SOLID TUMOR; WEIGHT REDUCTION;

EID: 0029764554     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.25166000.x     Document Type: Article

References (45)

1. Smith DE, Stevens MC, Booth IW. Malnutriton at diagnosis of malignancy in childhood: common but mostly missed. Eur J Pediatr 1991; 150: 318-22.
2. Jan Van Eys. Malnutrition in children with cancer. Incidence and consequence. Cancer 1979; 43: 2030-5.
3. DeWys WD. Anorexia as a general effect of cancer. Cancer 1979; 43: 2013-9.
4. Tchekmedyian NS. Nutr Clin Pract 1993; 8: 115-8.
5. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69: 491-7.
6. Arana T. Valoración del estado nutricional en el niño oncológico. Doctoral thesis, University of Navarra, Spain, 1993.
7. Rickard KA, Loghmani ES, Grossfeld JL, et al. Short- and long-term effectiveness of enteral and parenteral nutrition in preventing or reversing PEM in children with advanced neuroblastoma. Cancer 1985; 56: 2881-97.
8. Rickard KA, Bartlett Foland B, Detamore CM, et al. Effectiveness of central parenteral nutrition versus peripheral parenteral nutrition plus enteral nutrition in reversing protein, energy malnutrition in children with advanced neuroblastoma and Wilms' tumour: a prospective randomized study. Am J Clin Nutr 1983; 38: 445-56.
9. Moertel CG, Schutt AJ, Reitemeier RJ, et al. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 1974; 33: 1607-9.
10. Kardinal CG, Loprinzi CL, Schaid DJ, et al. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer 1990; 65: 2657-62.
11. Theologides A. Appetite in anorexia of cancer. Curr Concepts Nutr 1988; 16: 101-24.
12. Canetta R, Florentine S, Hunter H, Lenaz L. Megestrol acetate. Cancer Treat Rev 1983: 10: 141-57.
13. Tchekmedyian NS, Tait N, Moody M, Aisner J. High-dose megestrol acetate: A possible treatment for cachexia. J Am Med Ass 1987; 257: 1195-8.
14. Creagan ET, Ingle JN, Schut AJ, et al. A prospective randomised controlled trial of megestrol acetate among high-risk patients with resected malignant melanoma. Am J Clin Oncol 1989; 12: 152-5.
15. Tchekmedian NS, Tait N, Moody M, Greco A, Aisner J. Appetite stimulation with megestrol acetate in cachectic cancer patients. Semin Oncol 1986; 13 (Suppl. 4): 37-43.
16. Bruera E, Macmillan K, Kuehn N, Hanson J, MacDonald RN. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status and other symptoms in patients with advanced cancer. Cancer 1990; 66: 1279-82.
17. Von Roenn JH, Murphy RL, Weber KM, Williams LM, Weitzman SA. Megestrol acetate for treatment of cachexia associated with human immunodeficiency infection virus. Ann Intern Med 1989; 110: 667-8.
18. Von Roenn JH, Armstrong D, Kotler DP, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994; 121: 393-9.
19. Oster MH, Enders SR, Samuels SJ, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994; 121: 400-8.
20. Loprinzi CL, Schaid DJ, Dose AM, Burnham NL, Jensen MD. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 1993; 11: 152-4
21. Tchekmedyian NS, Hickman M, Siau J, et al Megestrol acetate in cancer anorexia and weight loss. Cancer 1992; 69: 1268-74.
22. Lansky LL, List MA, Lansky SB, Cohen ME, Sinks LF. Toward the development of a play performance scale for children (PPSC). Cancer 1985; 56: 1837-40.
23. Gibson RS. Principles of Nutritional Assessment. New York: Oxford University, 1990: 190-205.
24. Hernández M, Castellet J. Curvas y tablas de crecimiento. Instituto de investigación sobre crecimiento y desarrollo. Fundación F. Orbegozo, Bilbao. Editorial Garsi, Madrid, 1988.
25. Loprinzi CL, Michalak JC, Schaid DJ, et al. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 1993; 11: 762-7.
26. Sancho Cuesta JF, Menéndez Fernández P, Avial Ines C, et al. Megestrol acetate and weight loss in advanced cancer. ECCO-7, S204.
27. Feliu J, González-Barón, Berrocal A, Ordoñez A, Barón-Saura JM. Treatment of cancer anorexia with megestrol acetate: Which is the optimal dose? J Natl Cancer Inst 1991; 83: 449. (Letter.)
28. Feliu J, González-Barón M, Berrocal A, et al. Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study. Am J Clin Oncol 1992; 15: 436-40.
29. Schmoll E, Wilke H, Thole R, et al. Megestrol acetate in cancer cachexia. Semin Oncol 1991; 1 (Suppl. 2): 32-4.
30. Tchekmedyian NS, Hickman M, Siau J, Greco A, Aisner J. Treatment of cancer anorexia with megestrol acetate: Impact on quality of life. Oncology 1990; 4: 185-92.
31. Reitmeier M, Hartenstein RC. Megestrol acetate and determination of body composition by bioelectrical impedance analysis in cancer cachexia. Proc Am Soc Clin Oncol 1990; 9: 325. (Abstract.)
32. Leiter LA, Marliss EB. Survival during fasting may depend on fat as well as protein stores. J Am Med Ass 1982; 248: 2306-7.
33. Aisner J, Tchekmedyian NS, Tait N, Parnes H, Novak M. Studies of high-dose megestrol acetate: potential applications in cachexia. Semin Oncol 1988; 15 (Suppl. 1): 68-75.
34. Loprinzi CL, Ellison NM, Schaid DJ, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 1990; 82: 1127-32.
35. Ansfield FJ. Megace and no diabetes mellitus. Ann Intern Med 1977; 86: 365.
36. Bottino JC, Tashima CK. Medroxyprogesterone acetate and diabetes mellitus. Ann Intern Med 1976; 84: 341.
37. Hamburger AW, Parnes H, Gordon GB, et al. Megestrol acetate-induced differentiation of 3T3-L1 adipocytes in vitro. Semin Oncol 1988; 15 (Suppl. 1): 76-8.
38. Conard J, Sumama M. In: Bardin CW, Milgrom E, Mauvais-Javais P, eds. The Effects of Progestins on Coagulation. New York: Raven Press, 1983, 447-52.
39. Tislade MJ. Cancer cachexia. Anti-Cancer Drugs 1993; 4: 115-25.
40. Keller U. Pathophisiology of cancer cachexia. Support Care Cancer 1993; 1: 290-4.
41. Saarinen UM, Koskelo EK, Teppo AM, et al. Tumor necrosis factor in children with malignancies. Cancer Res 1990; 50: 592-5.
42. Tchekmedyian NS, Halpert C, Ashey J, et al. Nutrition in advanced cancer: anorexia as an outcome variable and target of therapy. J Parenteral Enteral Nutr 1992; 16: 88S-92S.
43. Loprinzi CL, Jensen MD, Jiang NS, Schaid DJ. Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc 1992; 67: 1160-2.
44. Alexieva-Figusch J, Blankenstein MA, de Jong FH, Lamberts SW. Endocrine effects of the combination of megestrol acetate and Tamoxifen in the treatment of metastatic breast cancer. Eur J Cancer Oncol 1984; 20: 1135-40.
45. Alexieva-Figusch J, Blankenstein MA, Hop WCJ, et al. Treatment of metastatic breast cancer patients with different dosages of megestrol acetate: dose relations, metabolic and endocrine effects. Eur J Clin Oncol 1984; 20: 33-40.